• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心肌梗死候选多态性的遗传效应与偏倚:病例研究及大规模证据综述

Genetic effects versus bias for candidate polymorphisms in myocardial infarction: case study and overview of large-scale evidence.

作者信息

Ntzani Evangelia E, Rizos Evangelos C, Ioannidis John P A

机构信息

Clinical and Molecular Epidemiology Unit, Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina, Greece.

出版信息

Am J Epidemiol. 2007 May 1;165(9):973-84. doi: 10.1093/aje/kwk085. Epub 2007 Feb 10.

DOI:10.1093/aje/kwk085
PMID:17293603
Abstract

Several genetic polymorphisms have been proposed to be associated with myocardial infarction (MI). The authors examined the evidence and biases underlying such associations using a case-study meta-analysis and an overview of large-scale data. In a meta-analysis of 27 studies addressing the association of the angiotensin type 1 receptor (AT1R)+1166A/C polymorphism with MI (10,180 cases, 17,129 controls), the *C allele conferred an increase in MI risk (odds ratio = 1.13 per allele, p = 0.005). However, there was large between-study heterogeneity; the largest study showed no effect, contradicting smaller studies; and studies with blinded genotyping showed no effect. The authors conducted an overview of meta-analyses of genetic associations for MI or coronary artery disease, including at least three studies and 3,000 subjects. In their latest meta-analysis, another 14 polymorphisms were found to have formally significant associations. If true, these associations would already explain 42% of the MI risk for Caucasian populations. Significant between-study heterogeneity was common. Across the 32 largest studies, only two found formally significant results (nine would be expected if each meta-analysis showed a true association). Even with large-scale evidence from meta-analyses, significant associations for MI may be subject to bias. Large-scale single studies and prospective consortia should be used for detecting and validating the genetic determinants of MI.

摘要

已有研究提出几种基因多态性与心肌梗死(MI)相关。作者通过病例研究的荟萃分析和大规模数据概述,对这些关联背后的证据和偏差进行了研究。在一项针对血管紧张素1型受体(AT1R)+1166A/C多态性与MI关联的27项研究的荟萃分析中(10180例病例,17129例对照),C等位基因使MI风险增加(每等位基因优势比=1.13,p=0.005)。然而,研究间存在很大的异质性;最大的研究显示无效应,这与较小规模的研究结果相矛盾;而采用盲法基因分型的研究也显示无效应。作者对MI或冠状动脉疾病的基因关联荟萃分析进行了概述,这些分析至少包括三项研究和3000名受试者。在他们最新的荟萃分析中,又发现另外14种多态性存在形式上显著的关联。如果这些关联是真实的,那么它们将已经能够解释白种人群中42%的MI风险。研究间显著的异质性很常见。在32项最大规模的研究中,只有两项得出了形式上显著的结果(如果每项荟萃分析都显示出真实关联,预计会有9项)。即使有来自荟萃分析的大规模证据,MI的显著关联仍可能存在偏差。大规模的单项研究和前瞻性联合研究应用于检测和验证MI的基因决定因素。

相似文献

1
Genetic effects versus bias for candidate polymorphisms in myocardial infarction: case study and overview of large-scale evidence.心肌梗死候选多态性的遗传效应与偏倚:病例研究及大规模证据综述
Am J Epidemiol. 2007 May 1;165(9):973-84. doi: 10.1093/aje/kwk085. Epub 2007 Feb 10.
2
Quantitative assessment of the effect of angiotensinogen gene polymorphisms on the risk of coronary heart disease.血管紧张素原基因多态性对冠心病风险影响的定量评估。
Circulation. 2007 Sep 18;116(12):1356-66. doi: 10.1161/CIRCULATIONAHA.107.728857. Epub 2007 Sep 10.
3
Angiotensin-converting enzyme insertion/deletion gene polymorphic variant as a marker of coronary artery disease: a meta-analysis.血管紧张素转换酶插入/缺失基因多态性变异作为冠状动脉疾病的标志物:一项荟萃分析。
Arch Intern Med. 2008 May 26;168(10):1077-89. doi: 10.1001/archinte.168.10.1077.
4
Epistatic interaction between haplotypes of the ghrelin ligand and receptor genes influence susceptibility to myocardial infarction and coronary artery disease.胃饥饿素配体和受体基因单倍型之间的上位相互作用影响心肌梗死和冠状动脉疾病的易感性。
Hum Mol Genet. 2007 Apr 15;16(8):887-99. doi: 10.1093/hmg/ddm033. Epub 2007 Feb 26.
5
Polymorphisms in thrombospondin genes and myocardial infarction: a case-control study and a meta-analysis of available evidence.血小板反应蛋白基因多态性与心肌梗死:一项病例对照研究及现有证据的荟萃分析。
Hum Mol Genet. 2008 Apr 15;17(8):1120-6. doi: 10.1093/hmg/ddn001. Epub 2008 Jan 4.
6
Inflammatory cytokine gene variants in coronary artery disease patients in Greece.希腊冠心病患者炎症细胞因子基因变异
Coron Artery Dis. 2008 Dec;19(8):575-82. doi: 10.1097/MCA.0b013e32831286e8.
7
Common polymorphisms in the cannabinoid CB2 receptor gene (CNR2) are not associated with myocardial infarction and cardiovascular risk factors.大麻素CB2受体基因(CNR2)的常见多态性与心肌梗死和心血管危险因素无关。
Int J Mol Med. 2008 Aug;22(2):165-74.
8
Thrombospondin-4 1186G>C (A387P) is a sex-dependent risk factor for myocardial infarction: a large replication study with increased sample size from the same population.血小板反应蛋白-4 1186G>C(A387P)是心肌梗死的性别依赖性风险因素:一项来自同一人群、样本量增加的大型重复研究。
Am Heart J. 2006 Sep;152(3):543.e1-5. doi: 10.1016/j.ahj.2006.06.002.
9
Associations with myocardial infarction of six polymorphisms selected from a three-stage genome-wide association study.从一项三阶段全基因组关联研究中选取的六个多态性与心肌梗死的关联。
Am Heart J. 2007 Nov;154(5):969-75. doi: 10.1016/j.ahj.2007.06.032.
10
Association of the angiotensin II type I receptor gene +1166 A>C polymorphism with hypertension risk: evidence from a meta-analysis of 16474 subjects.血管紧张素 II 型 1 型受体基因+1166 A>C 多态性与高血压风险的关联:来自 16474 例个体的荟萃分析证据。
Hypertens Res. 2010 Nov;33(11):1137-43. doi: 10.1038/hr.2010.156. Epub 2010 Aug 12.

引用本文的文献

1
Case-Control Study on the Interaction Effects of rs10757278 Polymorphisms at 9p21 Locus and Traditional Risk Factors on Coronary Heart Disease in Xinjiang, China.9p21 位点 rs10757278 多态性与传统危险因素在中国新疆地区冠心病的病例对照研究的交互作用
J Cardiovasc Pharmacol. 2020 May;75(5):439-445. doi: 10.1097/FJC.0000000000000807.
2
Angiotensin II Type 1 Receptor Gene A1166C Polymorphism Was Not Associated With Acute Coronary Syndrome in an Iranian Population.血管紧张素II 1型受体基因A1166C多态性与伊朗人群急性冠脉综合征无关。
Iran Red Crescent Med J. 2016 Jul 9;18(11):e23942. doi: 10.5812/ircmj.23942. eCollection 2016 Nov.
3
Circulating micro ribonucleic acids in cardiovascular disease: a look beyond myocardial injury.
心血管疾病中的循环微小核糖核酸:超越心肌损伤的探讨
Ann Transl Med. 2016 Oct;4(Suppl 1):S30. doi: 10.21037/atm.2016.10.67.
4
Cardiac biomarkers.心脏生物标志物
Dis Markers. 2015;2015:370569. doi: 10.1155/2015/370569. Epub 2015 Apr 19.
5
A test for reporting bias in trial networks: simulation and case studies.试验网络中报告偏倚的检测:模拟与案例研究
BMC Med Res Methodol. 2014 Sep 27;14:112. doi: 10.1186/1471-2288-14-112.
6
Biomarker tests for risk assessment in coronary artery disease: will they change clinical practice?用于冠状动脉疾病风险评估的生物标志物检测:它们会改变临床实践吗?
Mol Diagn Ther. 2014 Feb;18(1):5-15. doi: 10.1007/s40291-013-0057-0.
7
The geometric increase in meta-analyses from China in the genomic era.基因组时代中国meta 分析数量的几何级增长。
PLoS One. 2013 Jun 12;8(6):e65602. doi: 10.1371/journal.pone.0065602. Print 2013.
8
A genetic risk score is associated with incident cardiovascular disease and coronary artery calcium: the Framingham Heart Study.遗传风险评分与心血管疾病和冠状动脉钙化的发生相关:弗雷明汉心脏研究。
Circ Cardiovasc Genet. 2012 Feb 1;5(1):113-21. doi: 10.1161/CIRCGENETICS.111.961342. Epub 2012 Jan 10.
9
Thirty-five common variants for coronary artery disease: the fruits of much collaborative labour.35 个常见的冠心病变异体:众多合作努力的成果。
Hum Mol Genet. 2011 Oct 15;20(R2):R198-205. doi: 10.1093/hmg/ddr384. Epub 2011 Aug 29.
10
Genetic testing and common disorders in a public health framework: how to assess relevance and possibilities. Background Document to the ESHG recommendations on genetic testing and common disorders.公共卫生框架下的基因检测与常见疾病:如何评估相关性及可能性。欧洲人类遗传学学会关于基因检测与常见疾病建议的背景文件
Eur J Hum Genet. 2011 Apr;19 Suppl 1(Suppl 1):S6-44. doi: 10.1038/ejhg.2010.249.